Cabbacis Receives SEC Notice of Qualification for Regulation A Offering
Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco-product manufacturer focused on harm-reduction products being developed under the iBlend™ brand name, confirmed that on June 3rd the U.S. Securities and Exchange Commission (SEC) qualified the Company’s Offering Statement on Form 1-A for a Regulation A (Tier 2) offering.
Cabbacis Granted European Patent for Vaporizer Pods
Cabbacis LLC, a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on harm reduction products, today announced that the European Patent Office (EPO) has issued a patent to Cabbacis on July 19, 2023 for vaporizer pods for use with oral electronic vaporizers.
Cabbacis Announces Canadian Patents for Very-Low-Nicotine Tobacco Products
Cabbacis LLC, a U.S. federally-licensed tobacco product manufacturer focused on harm reduction products, today announced that the Canadian Intellectual Property Office (CIPO) has issued Patent No. 3,151,047 to Cabbacis for pods comprising blends of very-low-nicotine tobacco and hemp for use with oral electronic vaporizers.
